Aramco’s Prosperity7 powers AI drug firm Insilico’s $95M round
TechCrunch
AUGUST 10, 2022
Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a “biotech winter.” Insilico uses machine learning to identify potential drug targets and eventually create the drug. while hardware production happened in China.
Let's personalize your content